SECTION 310:515-1-4. Additional diseases, conditions, and injuries to be reported

  The following diseases, conditions and injuries must be reported by physicians, laboratories, and hospitals (by infection control practitioners, medical records personnel, and other designees) to the OSDH as dictated in the following subsections:

(1)   Infectious diseases. Reports of infectious diseases and conditions listed in this subsection must be submitted electronically via the PHIDDO system, telephoned or submitted via secure electronic data transmission to the OSDH within one (1) working day (Monday through Friday, state holidays excepted) of diagnosis or positive test.

(A)   Acid Fast Bacillus (AFB) positive smear. Report only if no additional testing is performed or subsequent testing is indicative of Mycobacterium tuberculosis Complex.

(B)   AIDS.

(C)   Anaplasma phagocytophilum infection.

(D)   Arboviral infections (West Nile virus, St. Louis encephalitis virus, Eastern equine encephalitis virus, Western equine encephalitis virus, Powassan virus, California serogroup virus, chikungunya virus, Zika virus).

(E)   Brucellosis (Brucella spp.).

(F)   Campylobacteriosis (Campylobacter spp.).

(G)   Congenital rubella syndrome.

(H)   Cryptosporidiosis (Cryptosporidium spp.).

(I)   Cyclosporiasis (Cyclospora cayetanensis).

(J)   Dengue Fever.

(K)   E. coli O157, O157:H7, or a Shiga toxin producing E. coli. (STEC)

(L)   Ehrlichiosis (Ehrlichia spp.).

(M)   Haemophilus influenzae invasive disease.

(N)   Hantavirus infection, without pulmonary syndrome.

(O)   Hantavirus pulmonary syndrome.

(P)   Hemolytic uremic syndrome, postdiarrheal.

(Q)   Hepatitis A infection (Anti-HAV-IgM+).

(R)   Hepatitis B infection. If any of the following are positive, then all test results on the hepatitis panel must be reported: HBsAg+, anti-HBc-IgM+, HBeAg+, or HBV DNA+.

(S)   Hepatitis C infection in persons having jaundice or ALT > or = 200 with laboratory confirmation. If hepatitis C EIA is confirmed by NAT for HCV RNA, or s/co ratio or index is predictive of a true positive then report results of the entire hepatitis panel.

(T)   HIV.

(U)   Influenza-associated hospitalization or death.

(V)   Legionellosis (Legionella spp.)

(W)   Leptospirosis (Leptospira interrogans).

(X)   Listeriosis (Listeria monocytogenes).

(Y)   Lyme disease (Borrelia burgdorferi).

(Z)   Malaria (Plasmodium spp.).

(AA)   Mumps.

(BB)   Pertussis (Bordetella pertussis).

(CC)   Psittacosis (Chlamydophila psittaci).

(DD)   Q fever (Coxiella burnetii).

(EE)   Rubella.

(FF)   Salmonellosis (Salmonella spp.).

(GG)   Shigellosis (Shigella spp.).

(HH)   Spotted Fever Rickettsiosis (Rickettsia spp.) hospitalization or death.

(II)   Streptococcal disease, invasive, Group A (GAS) (Streptococcus pyogenes).

(JJ)   Streptococcus pneumoniae invasive disease, in persons less than 5 years of age.

(KK)   Syphilis (Treponema pallidum). Nontreponemal and treponemal tests are reportable. If any syphilis test is positive, then all syphilis test results on the panel must be reported. For infants < or = 18 months, all syphilis tests ordered, regardless of test result, must be reported.

(LL)   Tetanus (Clostridium tetani).

(MM)   Trichinellosis (Trichinella spiralis).

(NN)   Tuberculosis (Mycobacterium tuberculosis).

(OO)   Tularemia (Francisella tularensis).

(PP)   Unusual disease or syndrome.

(QQ)   Vibriosis (Vibrionaceae family: Vibrio spp. (including cholera), Grimontia spp., Photobacterium spp., and other genera in the family).

(RR)   Yellow Fever.

(2)   Infectious diseases. Reports of infectious diseases and conditions listed in this subsection must be reported to the OSDH within one (1) month of diagnosis or test result.

(A)   CD4 cell count with corresponding CD4 cell count percentage of total (by laboratories only).

(B)   Chlamydia (Chlamydia trachomatis).

(C)   Creutzfeldt-Jakob disease.

(D)   Gonorrhea (Neisseria gonorrhoeae).

(E)   HIV viral load (by laboratories only).

(F)   LGV.

(3)   Occupational or environmental diseases. Laboratories and healthcare provides must report blood lead level results pursuant to the requirements established in Title 310, Chapter 512, childhood Lead Poisoning Prevention Rules.

(4)   Injuries.

(A)   Burns.

(B)   Drownings and near drownings.

(C)   Traumatic brain injuries.

(D)   Traumatic spinal cord injuries.

(E)   Poisonings, including toxic and adverse effects.

[Source: Amended at 9 Ok Reg 485, eff 1-1-92 (emergency); Amended at 9 Ok Reg 1429, eff 5-1-92; Amended at 10 Ok Reg 1997, eff 6-1-93; Amended at 11 Ok Reg 3837, eff 7-11-94; Amended at 17 Ok Reg 2942, eff 7-13-00; Amended at 19 Ok Reg 1285, eff 5-28-02; Amended at 20 Ok Reg 2366, eff 7-11-03; Amended at 24 Ok Reg 1978, eff 6-25-07; Amended at 26 Ok Reg 2033, eff 6-25-09; Amended at 27 Ok Reg 2522, eff 7-25-10; Amended at 29 Ok Reg 1601, eff 7-12-12; Amended at 31 Ok Reg 1588, eff 9-12-14; Amended at 34 Ok Reg 1287, eff 10-1-17; Amended at 36 Ok Reg 1685, eff 9-13-19; Amended at 37 Ok Reg 1408, eff 9-11-20]